News & Events

You are here

18/07/16

Video Recording: Australia: Preferred Destination for Early Phase Clinical Trials

BEIJING, CHINA - 18 May 2016 | Frost & Sullivan today presented highlights from new research into why Australia is a hub for early phase clinical trials (DIA China, Beijing, May 18, 2016).  The study was supported by Novotech, Australia’s...

26/05/16

Novotech and Frost & Sullivan Present New Data at DIA China on Australia’s Edge in Early Phase Clinical Trials

BEIJING, CHINA - 18 May 2016 | Frost & Sullivan today presented highlights from new research into why Australia is a hub for early phase clinical trials (DIA China, Beijing, May 18, 2016).  The study was supported by...

26/05/16

Webinar - Navigating Oncology Trials in Asia: How a Regional CRO can Deliver on a Global Project

Worldwide, there were an estimated 14.1 million new cancer cases in 2012 (American Cancer Society). Almost half of these occur in Asia with almost one quarter of the global burden in China. The top three cancers in women are breast, lung, and...

25/02/16

Webinar - Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors

Governments in Asian countries increasingly view biomedical/life sciences industry as a key segment for future economic growth. Substantial financial support has been granted to this segment resulting in improved clinical research infrastructure...

08/01/16

Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors, Upcoming Webinar Hosted by Xtalks

Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors, Upcoming Webinar Hosted by Xtalks  
TORONTO, ON--(Marketwired - January 07, 2016) - Join industry experts from Novotech including John Moller, Chief Operating Officer (Asia),...

15/12/15

Novotech appointed Contract Research Organisation for upcoming Phase 1b/2 study of HER-Vaxx in gastric cancer

Novotech appointed Contract Research Organisation for upcoming Phase 1b/2 study of HER-Vaxx in gastric cancer

 

 ...

27/11/15

NOVOGEN ENGAGES CONTRACT RESEARCH ORGANISATION TO CONDUCT CANTRIXIL PHASE 1 CLINICAL TRIAL

02/03/15

Novotech leads the fast growing Asia Pacific clinical research sector with another Frost & Sullivan "CRO BEST PRACTICE AWARD"

Sydney, Australia, February 17, 2015

Novotech, the largest Australia-based clinical CRO with offices throughout the Asia region, has just been awarded the CRO Best Practice Award for the third time in recent years by Frost...

19/01/15

Australian clinical research company expands operation in Hong Kong

Sydney-based Novotech today (January 15) announced that it has expanded its Hong Kong operation into a permanent office with more staff to meet the increasing demand in the pharmaceutical market for clinical research.

The company began...

19/12/14

SureClinical eTMF Cloud Selected by Novotech to automate and accelerate clinical operations processes

Pages